Organogenesis Holdings (ORGO) Cash & Equivalents Growth (1y) (2016 - 2026)
Organogenesis Holdings (ORGO) Cash & Equivalents Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | -39.02% |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 120.45% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 12.78% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 50.32% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -32.64% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 138.97% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 37.30% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -12.11% |
| 10 | Organogenesis Holdings | 323.97 Mn | 231.87 Mn | 11.46 Mn | -16.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.90% |
| Dec 31, 2025 | -30.90% |
| Sep 30, 2025 | -32.43% |
| Jun 30, 2025 | -18.72% |
| Mar 31, 2025 | 24.08% |
| Dec 31, 2024 | 30.56% |
| Sep 30, 2024 | -3.96% |
| Jun 30, 2024 | 1.11% |
| Mar 31, 2024 | -0.08% |
| Dec 31, 2023 | 1.33% |
| Sep 30, 2023 | -8.41% |
| Jun 30, 2023 | -20.81% |
| Mar 31, 2023 | -17.80% |
| Dec 31, 2022 | -10.05% |
| Dec 31, 2021 | 35.00% |
| Sep 30, 2018 | 268,556.74% |
| Jun 30, 2018 | 109,801.14% |
| Mar 31, 2018 | -79.54% |
| Dec 31, 2017 | -87.90% |
| Sep 30, 2017 | -31.49% |